The following conditions shall be applicable to offers and sales made under Regulation D (§230.500et seq. of this chapter):
NOTE: When an issuer provides information to investors pursuant to paragraph (b)(1), it should consider providing such information to accredited investors as well, in view of the anti-fraud provisions of the federal securities laws.
While taking these actions will establish the requisite reasonable care, it is not the exclusive method to demonstrate such care. Other actions by the issuer may satisfy this provision. In addition, § 230.502(b)(2) (vii) requires the delivery of written disclosure of the limitations on resale to investors in certain instances.
17 C.F.R. §230.502